Edition:
United Kingdom

Uniqure NV (QURE.OQ)

QURE.OQ on NASDAQ Stock Exchange Global Select Market

33.41USD
23 May 2018
Change (% chg)

$1.07 (+3.31%)
Prev Close
$32.34
Open
$32.33
Day's High
$35.70
Day's Low
$32.33
Volume
138,910
Avg. Vol
116,884
52-wk High
$35.70
52-wk Low
$4.92

Chart for

About

Uniqure NV is a gene therapy company based in the Netherlands. The Company is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. The Company advances a focused pipeline of gene therapies that are developed both... (more)

Overall

Beta: 0.51
Market Cap(Mil.): $274.23
Shares Outstanding(Mil.): 25.63
Dividend: --
Yield (%): --

Financials

  QURE.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -- -- --
ROI: -- 1.57 14.38
ROE: -- 2.43 16.07

BRIEF-Uniqure Receives Orphan Medicinal Product Designation In Europe For Amt-130 In Huntington’S Disease

* UNIQURE RECEIVES ORPHAN MEDICINAL PRODUCT DESIGNATION IN EUROPE FOR AMT-130 IN HUNTINGTON’S DISEASE Source text for Eikon: Further company coverage:

22 Jan 2018

BRIEF-Uniqure Says As Of Dec 31 Co Had $159 Mln In Cash & Cash Equivalents

* UNIQURE PROVIDES YEAR-END 2017 CORPORATE UPDATE AND OUTLINES NEAR-TERM OBJECTIVES TO FURTHER DRIVE SHAREHOLDER VALUE

08 Jan 2018

Competitors

Earnings vs. Estimates